Curative treatment with extracts of Bombax ceiba fruit reduces risk of calcium oxalate urolithiasis in rats

Pharmaceutical Biology

Volumn 50, Issue 3, 2012, Pages 310-317

  Gadge, N B ^a   Jalalpure, S S ^a  

^a K L E S S COLLEGE OF PHARMACY   (India)

Author keywords

Bombacaceae; Hyperoxaluria; Kidney; Renal calculi

Indexed keywords

ALCOHOL; ANTIUROLITHIASIS AGENT; BOMBAX CEIBA EXTRACT; CARBOHYDRATE; CYSTONE; ETHYLENE GLYCOL; FLAVONOID; HERBACEOUS AGENT; PHENOL DERIVATIVE; PLANT GLYCOSIDE; TANNIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; BOMBAX; BOMBAX CEIBA; CALCIUM EXCRETION; CALCIUM OXALATE STONE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; DRUG TARGETING; EXPERIMENTAL RAT; FEMALE; FRUIT; HYPEROXALURIA; MALE; NONHUMAN; PHOSPHATE EXCRETION; RAT; REGULATORY MECHANISM; RISK REDUCTION;

ANIMALS; BOMBAX; CALCIUM; CALCIUM OXALATE; DISEASE MODELS, ANIMAL; ETHYLENE GLYCOL; FEMALE; FRUIT; HYPEROXALURIA; MALE; MEDICINE, TRADITIONAL; PHOSPHATES; PLANT EXTRACTS; RATS; RATS, WISTAR; UROLITHIASIS;

BOMBAX CEIBA; MALVACEAE; RATTUS;

EID: 84856866444     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2011.604332     Document Type: Article

References (53)

1. Adhirai M, Selvam R. (1997). Vitamin E pretreatment prevents cyclosporine A-induced crystal deposition in hyperoxaluric rats. Nephron, 75, 77-81. (Pubitemid 27052941)
2. Anand R, Patnaik GK, Kulshrestha DK, Dhawan BN. (1991). Antiurolithiatic and diuretic activity of lupeol. Proceedings of 24th and 25th Pharmacology Society Conference; A-10.
3. Anand R, Patnaik GK, Kulshrestha DK, Dhawan BN. (1992). Antiurolithiatic and diuretic activity of lupeol, the active constituent isolated from Crataeva nurvala (Buch Ham). Indian J Pharmacol, 24, 48-49
4. Anonymous. (2001). OECD series on testing and assessment, Number 24. Guidance document on acute oral toxicity testing. ENV/JM/MONO(2001)4. Paris: Environment directorate, OECD.
5. Atmani F, Slimani Y, Mimouni M, Hacht B. (2003). Prophylaxis of calcium oxalate stones by Herniaria hirsuta on experimentally induced nephrolithiasis in rats. BJU Int, 92, 137-140. (Pubitemid 36843044)
6. Balaji KC, Menon M. (1997). Mechanism of stone formation. Urol Clin North Am, 24, 1-11. (Pubitemid 27098680)
7. Baskar R, Malini MM, Varalakshmi P, Balakrishna K, Bhimarao R. (1996). Efect of lupeol isolated from Crataeva nurvala stem bark against free radical-induced toxicity in experimental urolithiasis. Fitoterapia, 67, 121-125. (Pubitemid 26173129)
8. Begun FP, Knoll CE, Gottlieb M, Lawson RK. (1991). Chronic efects of focused electrohydraulic shock waves on renal function and hypertension. J Urol, 145, 635-639.
9. Bijikurien T, Selvam R. (1987). Induction of lipid peroxidation by oxalate in experimental rat urolithiasis. J Biosci, 12, 367-373.
10. Bühler H, Perschel FH, Hierholzer K. (1991). Inhibition of rat renal 11 beta-hydroxysteroid dehydrogenase by steroidal compounds and triterpenoids; structure/function relationship. Biochim Biophys Acta, 1075, 206-212.
11. Caraway WT. (1963). Uric acid. In: Seligson D, ed. Standard Methods Clinical Chemistry. New York and London: Academic Press, 4, 239.
12. Chow FC, Dysart MI, Hamar DW, Udall RH. (1975). Control of oxalate urolithiasis by DL-alanine. Invest Urol, 13, 113-116.
13. Dar A, Faizi S, Naqvi S, Roome T, Zikrur-Rehman S, Ali M, Firdous S, Moin ST. (2005). Analgesic and antioxidant activity of mangiferin and its derivatives: the structure activity relationship. Biol Pharm Bull, 28, 596-600. (Pubitemid 40879921)
14. Denstedt JD, Singal RK. (1997). Contemporary management of ureteral stones. Urol Clin North Am, 24, 68.
15. Ernster L, Nordenbrand K. (1967). Oxidation and phosphorylation. In: Ronald WE, Maynard EP, eds. Methods in Enzymology. Vol. X. New York: Academic Press; 574-580.
16. Fiske CH, Subbarow Y. (1925). The colorimetric determination of phosphate. J Biol Chem, 66, 375-381.
17. Gadge NB, Jalalpure SS, Pawase KB. (2009). Preliminary phytochemical screening and diuretic activity of Bombax ceiba L. fruit extracts. Pharmacologyonline, 3, 188-194.
18. Ghodkar PB. (1994). Chemical tests in kidney disease. In: Textbook of Medical Laboratory Technology. 1st ed. Mumbai: Bhalani Publishing House; 118-132.
19. Gopal H, Gupta RK. (1972). Chemical constituents of Salmalia malabarica Schott and Endl. fowers. J Pharm Sci, 61, 807-808.
20. Hodgkinson A, Williams A. (1972). An improved colorimetric procedure for urine oxalate. Clin Chim Acta, 36, 127-132.
21. Huang HS, Ma MC, Chen J, Chen CF. (2002). Changes in the oxidant-antioxidant balance in the kidney of rats with nephrolithiasis induced by ethylene glycol. J Urol, 167, 2584-2593. (Pubitemid 34533185)
22. Kapoor LD. (1990). Handbook of Ayurvedic Medicinal Plants. Boca Raton: CRC Press.
23. Khandelwal KR. (2002). Practical Pharmacognosy, Techniques and Experiments. 9th ed. Pune: Nirali Prakashan.
24. Kirtikar KR, Basu BD. (1980). Indian Medicinal Plants. 2nd ed., Vol. I. Dehradun: International Book Distributors.
25. Krishnamurthy MS, Hruska KA, Chandhoke PS. (2003). The urinary response to an oral oxalate load in recurrent calcium stone formers. J Urol, 169, 2030-2033. (Pubitemid 36576710)
26. Lemann J Jr, Worcestor EM, Gray RW. (1991). Hypercalciuria and stones. Am J Kidney Dis, 27, 386-391.
27. Malini MM, Baskar R, Varalakshmi P. (1995). Efect of lupeol, a pentacyclic triterpene, on urinary enzymes in hyperoxaluric rats. Jpn J Med Sci Biol, 48, 211-220. (Pubitemid 26047929)
28. Mehra PN, Karnick CR. (1968). Pharmacognostic studies on Bombax ceiba Linn. Indian J Pharm, 30, 284
29. Misra MB, Mishra SS, Misra RK. (1968). Pharmacology of Bombax malabaricum (DC). Indian J Pharm, 30, 165-166.
30. Mitra SK, Gopumadhavan S, Venkataranganna MV, Sundaram R. (1998). Efect of cystone, a herbal formulation, on glycolic acid-induced urolithiasis. Phytotherap Res, 12, 372-374. (Pubitemid 28366066)
31. Mukherjee J, Roy B. (1971). Chemical examination of Salmalia malabarica Schott Endl. (syn. Bombax malabaricum DC.). J Indian Chem Soc, 48, 769-770.
32. Mukherjee T, Bhalla N, Aulakh GS, Jain HC. (1984). Herbal drugs for urinary stones-Literature appraisal. Indian Drugs, 21, 224-228.
33. Mustafa MA, Medeiros DM. (1985). Proximate composition, mineral content and fatty acids of cat fsh (Ictalurus punctatus rafnesque) for diferent seasons and cooking methods. J Food Sci, 50, 585-588.
34. Muthukumar A, Selvam R. (1997). Efect of depletion of reduced glutathione and its supplementation by glutathione monoester on renal oxalate retention in hyperoxaluria. J Nutr Biochem, 8, 445-450. (Pubitemid 27362071)
35. Nadkarni AK, Nadkarni KM. (1976). Indian Materia Medica. 3rd ed., Vol. I. Popular Book Depot: Bombay.
36. Namsa ND, Tag H, Mandal M, Kalita P, Das AK. (2009). An ethnobotanical study of traditional anti-infammatory plants used by the Lohit community of Arunachal Pradesh, India. J Ethnopharmacol, 125, 234-245.
37. Prien EL, Prien EL Jr. (1968). Composition and structure of urinary stone. Am J Med, 45, 654-672.
38. Raghuramulu N, Madhavan NK, Kalyanasundaram S.(1983). In: A Manual of Laboratory Techniques. 1st ed. Hyderabad: National Institute of Nutrition; 34.
39. Richardson TKE, Tolbert NE. (1961). Oxidation of glycolic acid to oxalic acid by glycolic acid oxidase. J Biol Chem, 57, 816-882.
40. Rivers K, Shetty S, Menon M. (2000). When and how to evaluate a patient with nephrolithiasis. Urol Clin North Am, 27, 203-213. (Pubitemid 30196790)
41. Robertson WG, Peacock M. (1980). The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? Nephron, 26, 105-110. (Pubitemid 10034660)
42. Robertson WG.(1999). A simplifed procedure for assessing the biochemical risk of forming stones in patients with uric acid or calcium containing urinary calculi. In: Borghi L, Mesehi T, Briganti A, eds. Kidney Stones<. Cosenza, Italy: Editoriale Bios; 403-406.
43. Roger K, Low MD, Stoller ML. (1997). Uric acid nephrolithiasis. Urol Clin North Am, 24, 135-148.
44. Saleem R, Ahmad M, Hussain SA, Qazi AM, Ahmad SI, Qazi MH, Ali M, Faizi S, Akhtar S, Husnain SN. (1999). Hypotensive, hypoglycaemic and toxicological studies on the favonol C-glycoside shamimin from Bombax ceiba. Planta Med, 65, 331-334. (Pubitemid 29249906)
45. Saravanan N, Senthil D, Varalakshmi P. (1995). Efect of L-cysteine on lipid peroxidation in experimental urolithiatic rats. Pharmacol Res, 32, 165-169. (Pubitemid 26048393)
46. Selvam R, Kalaiselvi P, Govindaraj A, Bala Murugan V, Sathish Kumar AS. (2001). Efect of A. lanata leaf extract and Vediuppu chunnam on the urinary risk factors of calcium oxalate urolithiasis during experimental hyperoxaluria. Pharmacol Res, 43, 89-93. (Pubitemid 32577760)
47. Seshadri V, Batta AK, Rangaswamy S. (1971). Phenolic components of Bombax malabaricum (Root-Bark). Curr Sci, 40, 630-631.
48. Seshadri V, Batta AK, Rangaswamy S. (1973). Phenolic components of Bombax malabaricum. Indian J Chem, 11, 825
49. Singh D, Chopra K. (2004). The efect of naringin, a biofavonoid on ischemia-reperfusion induced renal injury in rats. Pharmacol Res, 50, 187-193. (Pubitemid 38737251)
50. Sumathi R, Jayanthi S, Kalpanadevi V, Varalakshmi P. (1993). Efect of DL alpha-lipoic acid on tissue lipid peroxidation and antioxidant systems in normal and glycollate treated rats. Pharmacol Res, 27, 309-318. (Pubitemid 23227051)
51. Tisselius HG. (1996). Solution chemistry of supersaturation. In: Coe Fl, Favus MJ, Pak CYC, Parks JH, Preminger GM, eds. Kidney Stones: Medical and Surgical Management. Philadelphia: Lippincott Reven; 33.
52. Vidya L, Varalakshmi P. (2000). Control of urinary risk factors of stones by betulin and lupeol in experimental hyperoxaluria. Fitoterapia, 71, 535-543. (Pubitemid 30646025)
53. Vieira TO, Said A, Aboutabl E, Azzam M, Creczynski-Pasa TB. (2009). Antioxidant activity of methanolic extract of Bombax ceiba. Redox Rep, 14, 41-46.